Showing 1 - 3 results of 3 for search 'O. Jaksic', query time: 0.02s Refine Results
  1. 1
    P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY

    P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY by M. Lucijanic, E. Soric, M. Sedinic, A. Sabljic, S. Tomasinec, A. Pasaric, M. Ivic, T. Vasilj, D. Cicic, Z. Jonjic, M. Pirsic, Z. Mitrovic, Z. Prka, V. Pejsa, R. Kusec, O. Jaksic

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM

    P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM by I. Aurer, S. Basic-Kinda, A. Grubesic, O. Jaksic, S. Mrdenovic, S. Novakovic-Coha, D. Lozic, M. Mikulic-Pisk, R. Serventi-Seiwerth, D. Dujmovic, A. Ostojic, B. Dreta, G. Pavlisa, M. Narancic, I. Hude-Dragicevic, T. Valkovic

    Published 2022-06-01
    Get full text
    Article
  3. 3
    S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA)

    S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) by M. S. Infante, J. Salmanton-García, A. Fernandez-Cruz, F. Marchesi, Z. RÁČIL, M. Hanakova, O. Jaksic, B. Weinbergerova, C. Besson, R. Duarte, F. Itri, T. VALKOVIĆ, A. Busca, A. Guidetti, A. GLENTHØJ, G. Collins, V. Bonuomo, U. Sili, G. Seval, M. Machado, A. Lopez-Garcia, R. Cordoba, O. Blennow, G. Abu-zeinah, S. Lemure, A. Kulasekararaj, I. Falces-Romero, C. Cattaneo, O. A. Cornely, J.-A. Hernandez-Rivas, L. Pagano

    Published 2022-06-01
    Get full text
    Article

Search Tools: